T2 Biosystems Depreciation & Amortization 2011-2026 | TTOO

Annual Depreciation & Amortization T2 Biosystems

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
859 K	1.05 M	1.27 M	1.71 M	2.2 M	2.45 M	2.94 M	2.28 M	1.46 M	691 K	584 K	571 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.94 M	571 K	1.51 M

Quarterly Depreciation & Amortization T2 Biosystems

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
100 K	100 K	64 K	-	100 K	100 K	256 K	-	300 K	200 K	286 K	-	300 K	300 K	383 K	-	400 K	400 K	503 K	-	500 K	600 K	557 K	-	600 K	600 K	629 K	-	2.19 M	1.43 M	694 K	-	1.63 M	1.07 M	529 K	-	979 K	600 K	253 K	-	459 K	299 K	144 K	-	438 K	284 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.19 M	64 K	522 K

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	264 K	-	-6.19 %	$ 10.5 M	USA
Bioventus BVS	47 M	$ 8.92	0.56 %	$ 594 M	USA
Castle Biosciences CSTL	16 M	$ 26.01	0.68 %	$ 722 M	USA
DexCom DXCM	252 M	$ 68.2	2.8 %	$ 26.6 B	USA
Charles River Laboratories International CRL	403 M	$ 154.35	1.57 %	$ 7.65 B	USA
CareDx, Inc CDNA	15 M	$ 17.52	1.18 %	$ 934 M	USA
Guardant Health GH	39.7 M	$ 87.53	0.4 %	$ 11 B	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	125 M	$ 103.87	0.01 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
Fulgent Genetics FLGT	24.9 M	$ 15.53	3.88 %	$ 470 M	USA
Biodesix BDSX	5.77 M	$ 17.01	-1.62 %	$ 2.21 B	USA
ICON Public Limited Company ICLR	488 M	$ 99.43	1.86 %	$ 8.2 B	Irlanda
Anixa Biosciences ANIX	38.3 K	$ 2.9	2.11 %	$ 94.1 K	USA
IQVIA Holdings IQV	1.14 B	$ 168.32	2.14 %	$ 28.9 B	USA
Danaher Corporation DHR	750 M	$ 194.97	1.87 %	$ 139 B	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	354 M	$ 121.42	1.79 %	$ 19.3 B	USA
Quest Diagnostics Incorporated DGX	570 M	$ 199.2	0.13 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	203 M	-	-	$ 10.6 B	Niderland
Agilent Technologies A	321 M	$ 113.43	1.43 %	$ 34.5 B	USA
BioNano Genomics BNGO	14 M	$ 1.12	0.66 %	$ 1.42 M	USA
DarioHealth Corp. DRIO	473 K	$ 9.28	10.24 %	$ 263 M	Israel
NeoGenomics NEO	36.1 M	$ 8.36	1.46 %	$ 1.07 B	USA
Neogen Corporation NEOG	119 M	$ 9.24	1.43 %	$ 2 B	USA
Lantheus Holdings LNTH	70.1 M	$ 78.46	-0.05 %	$ 5.3 B	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Pacific Biosciences of California PACB	13 M	$ 1.41	3.31 %	$ 423 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	1.23 M	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	27.2 M	$ 452.71	-0.21 %	$ 13.1 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	51.1 M	$ 1 215.3	1.35 %	$ 25 B	Schweiz
Celcuity CELC	130 K	$ 114.14	-0.66 %	$ 4.5 B	USA
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	7.62 M	$ 17.95	3.16 %	$ 402 M	USA
Invitae Corporation NVTA	142 M	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	16.7 M	$ 199.43	0.89 %	$ 19.6 B	USA
OPKO Health OPK	98.2 M	$ 1.2	0.42 %	$ 833 M	USA